A tumour stage-dependent evolution of drug resistant T cell lymphoma: Role of soluble mediators of tumour and host origin

Leukemia Research

Volumn 33, Issue 5, 2009, Pages 700-709

  Singh, Vivek ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; Cisplatin; Cytokines; Survival; T cell lymphoma; Tumour microenvironment

Indexed keywords

CAD PROTEIN; CISPLATIN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; NITRIC OXIDE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASCITES FLUID; CANCER RESISTANCE; CANCER STAGING; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; IMMUNODETECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T CELL LYMPHOMA; TUMOR GROWTH;

ANIMALS; BLOOD; BLOTTING, WESTERN; CELL SURVIVAL; CYTOKINES; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 61449135113     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.09.010     Document Type: Article

References (45)

1. Henkels K.M., and Turchi J.J. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 59 (1999) 3077-3083
2. Tavaluc R.T., Hart L.S., Dicker D.T., and El-Deiry W.S. Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 21 (2007) 6-20
3. Singh V., and Singh S.M. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs 18 (2007) 1123-1132
4. Schiller M., Franz S., Heyder P., Voll R.E., Gaipl U.S., Lorenz H.M., et al. Hypothesis: human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli. Apoptosis 13 (2008) 319-328
5. + blood progenitor cells. Blood 93 (1999) 746-755
6. Mahoney J., Lee H., Foster R., Matulonis U., Duan Z., and Seiden M.V. Evaluation of serial serum IL-6 levels in women with newly diagnosed ovarian cancer on a prospective clinical trial. J Clin Oncol 24 (2006) 5065
7. Roy R., Singh S.M., Shanker A., and Sodhi A. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1. Int J Immunopharmacol 22 (2000) 309-321
8. Stevens R.L., Bloes W.F., Seldin D.C., Razin E., Katz H.R., and Austen K.F. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype. J Immunol 133 (1984) 2674-2680
9. Nicola M.D., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
10. Parajuli P., Singh S.M., and Kumar A. Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Int J Immunopharmacol 17 (1995) 1-7
11. Ben-Effrain S. One hundred years of cancer immunotherapy: a critical appraisal. Tumor Biol 20 (1999) 1-24
12. Gupta V., and Singh S.M. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J Reprod Immunol 74 (2007) 90-102
13. Gupta V., and Singh S.M. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma. J Biomed Sci 15 (2008) 147-162
14. Armitage J.O., Vose J.M., and Weisenburger D.D. Towards understanding the peripheral T-cell lymphomas. Ann Oncol 15 (2004) 1447-1449
15. Singh M.P., Rai A.K., and Singh S.M. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones. J Reprod Immunol 65 (2005) 17-32
16. Kumar A., and Singh S.M. Effect of tumor growth on the blastogenic response of splenocytes: a role of macrophage derived nitric oxide. Immunol Invest 25 (1996) 413-423
17. Bharti A., and Singh S.M. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T-cell lymphoma: the involved mechanisms. Nitric Oxide 8 (2003) 75-82
18. Singh M.P., Sharma H., and Singh S.M. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines. Cancer Invest 24 (2006) 601-610
19. Singh M.P., Singh G., and Singh S.M. Paraneoplastic neurodegeneration in a murine host following progressive growth of a spontaneous T-cell lymphoma: role of proinflammatory internal responses. Neuroimmunomodulation 13 (2006) 122-132
20. Sellins K.S., and Cohen J.J. Nuclear changes in the cytotoxic T lymphocyte-induced model of apoptosis. Immunol Rev 146 (1995) 241-266
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72 (1976) 248-254
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65 (1983) 55-63
23. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and oxygen intermediates from murine peritoneal macrophages: comparison of the activation cytokines and independent production. J Immunol 141 (1988) 2407-2412
24. Bamias A., Koutsoukou V., Terpos E., Tsiatas M.L., Liakos C., Tsitsilonis O., et al. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. Gynecol Oncol 108 (2008) 421-427
25. Korsisaari N., Ross J., Wu X., Kowanetz M., Pal N., Hall L., et al. Blocking vascular endothelial growth factor-a inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Clin Cancer Res 14 (2008) 249-258
26. Ewan K.B., Henshall-Powell R.L., Ravani S.A., Pajares M.J., Arteaga C., Warters R., et al. Transforming growth factor-β1 mediates cellular response to DNA damage in situ. Cancer Res 62 (2002) 5627-5631
27. Aghdassi A., Phillips P., Dudeja V., Dhaulakhandi D., Sharif R., Dawra R., et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res 67 (2007) 616-625
28. Charo J., Finkelstein S.E., Grewal N., Restifo N.P., Robbins P.F., and Rosenberg S.A. Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res 65 (2005) 2001-2008
29. Kim J.G., Chae Y.S., Sohn S.K., Cho Y.Y., Moon J.H., Park J.Y., et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14 (2008) 62-66
30. Li X.C., Demirci G., Ferrari-Lacraz S., Groves C., Coyle A., Malek T.R., et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 7 (2001) 114-118
31. Yuan H., Liddle F.J., Mahajan S., and Frank D.A. IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor. Carcinogenesis 25 (2004) 2247-2255
32. Wolf J.S., Chen Z., Dong G., Sunwoo J.B., Bancroft C.C., Capo D.E., et al. IL (Interleukin)-1α promotes nuclear factor-κB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7 (2001) 1812-1820
33. Elaraj D.M., Weinreich D.M., Varghese S., Puhlmann M., Hewitt S.M., Carroll N.M., et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clini Cancer Res 12 (2006) 1088-1096
34. Wang L.S., Chow K.C., Li W.Y., Liu C.C., Wu Y.C., and Huang M.H. Clinical significance of serum soluble interleukin 2 receptor-α in esophageal squamous cell carcinoma. Clin Cancer Res 6 (2000) 1445-1451
35. Donovan D., Harmey J.H., Toomey D., Osborne D.H., Redmond H.P., and Bouchier-Hayes D.J. TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 4 (1997) 621-627
36. Dias S., Hattori K., Heissig B., Zhu Z., Wu Y., Witte L., et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 98 (2001) 10857-10862
37. Bartoli M., Platt D., Lemtalsi T., Gu X., Brooks S.E., Marrero M.B., et al. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17 (2003) 1562-1564
38. Hu J., Vaquero C., Huet S., Bernard A., and Sterkers G. Interleukin 2 up-regulates its own production. J Immunol 139 (1987) 4109-4115
39. Van Obberghen-Schilling E., Roche N.S., Flanders K.C., Sporn M.B., and Roberts A.B. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263 (1988) 7741-7746
40. Kumar C.A., Jayarama S., Basappa, Salimath B.P., and Rangappa K.S. Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells. Invest New Drugs 25 (2007) 343-350
41. Nylandsted J., Rohde M., Brand K., Bastholm L., Elling F., and Jäättela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97 (2000) 7871-7876
42. Torigoe T., Izumi H., Ishiguchi H., Yoshida Y., Tanabe M., Yoshida T., et al. Cisplatin resistance and transcription factors. Curr Med Chem Anti-Cancer Agents 5 (2005) 15-27
43. Donnelly R.P., Fenton M.J., Finbloom D.S., and Gerrard T.L. Differential regulation of IL-1 production in human monocytes by IFN- gamma and IL-4. J Immunol 145 (1990) 569-575
44. Hollenbaugh J.A., and Dutton R.W. IFN-γ regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J Immunol 177 (2006) 3004-3011
45. Maruyama K., Sano G., and Matsuo K. Murine osteoblasts respond to LPS and IFN-γ similarly to macrophages. J Bone Miner Metabol 24 (2006) 491-497